Arterial stiffness in Behçet’s disease: increased regional pulse wave velocity values

Diverse vascular lesions occur in about one third of patients with Behcet’s disease (BD). Endothelial dysfunction is known to have an important role in the development of these lesions.1 Acute systemic inflammation and chronic systemic vasculitis are associated with endothelial dysfunction.2,3 Moreover, inflammation is an important risk factor for future cardiovascular events.4 These findings have led to the hypothesis that acute and chronic inflammatory processes associated with BD may cause endothelial dysfunction, which can then lead to a subsequent increase of arterial stiffness and vascular damage that are closely related to the clinical course of BD. Arterial stiffness is a reliable predictor of subsequent cardiovascular mortality and vascular damage. Pulse wave velocity (PWV) is an ideal indicator of arterial stiffness.5,6 …

[1]  K. Kim,et al.  Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis , 2003, Annals of the rheumatic diseases.

[2]  J. Kooner,et al.  Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. , 2001, Journal of the American College of Cardiology.

[3]  A. Struthers,et al.  Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses , 2003, Journal of hypertension.

[4]  J. Izzo,et al.  Arterial stiffness and the systolic hypertension syndrome , 2004, Current opinion in cardiology.

[5]  Masanori Munakata,et al.  Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. , 2003, American journal of hypertension.

[6]  F. Parivar,et al.  Interstitial cystitis. , 1986, British journal of urology.

[7]  Aroon D. Hingorani,et al.  Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans , 1999, Circulation.

[8]  S. Ralston,et al.  Abnormal growth factor and cytokine expression in Dupuytren's contracture. , 1993, Journal of clinical pathology.

[9]  Zheng-guo Wang,et al.  Effect of substance P on gene expression of transforming growth factor beta-1 and its receptors in rat's fibroblasts. , 2003, Chinese journal of traumatology = Zhonghua chuang shang za zhi.

[10]  R. Teshima,et al.  Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. , 2002, American journal of physiology. Cell physiology.

[11]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[12]  R. Straub,et al.  The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Gallagher,et al.  Mast cells in pathological and surgical scars , 1998, The British journal of ophthalmology.

[14]  J. Townend,et al.  Endothelial Function : Lessons for Atherosclerotic Disease ? Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular , 2000 .

[15]  J. D. Saar,et al.  Dupuytren's disease: an overview. , 2000, Plastic and reconstructive surgery.

[16]  W. Alwan,et al.  T-cell-mediated response in Dupuytren's disease , 1993, The Lancet.

[17]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[18]  Shigeaki Hinohara,et al.  Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. , 2003, Atherosclerosis.

[19]  J. D. Spencer,et al.  Langerhans Cells in Dupuytren’s Contracture , 2001, Journal of hand surgery.

[20]  J. Crossan,et al.  Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids. , 1999, The Journal of bone and joint surgery. British volume.